Viruses 2013, 5(2), 577-594; doi:10.3390/v5020577
Review

Respiratory Syncytial Virus: Current Progress in Vaccine Development

1email, 1email, 1email, 1email and 1,2,* email
Received: 16 January 2013; in revised form: 1 February 2013 / Accepted: 4 February 2013 / Published: 5 February 2013
(This article belongs to the Special Issue Pneumoviruses and Metapneumoviruses)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Respiratory syncytial virus (RSV) is the etiological agent for a serious lower respiratory tract disease responsible for close to 200,000 annual deaths worldwide. The first infection is generally most severe, while re-infections usually associate with a milder disease. This observation and the finding that re-infection risks are inversely associated with neutralizing antibody titers suggest that immune responses generated toward a first RSV exposure can significantly reduce morbidity and mortality throughout life. For more than half a century, researchers have endeavored to design a vaccine for RSV that can mimic or improve upon natural protective immunity without adverse events. The virus is herein described together with the hurdles that must be overcome to develop a vaccine and some current vaccine development approaches.
Keywords: respiratory syncytial virus; candidate vaccines; protective immunity
PDF Full-text Download PDF Full-Text [246 KB, Updated Version, uploaded 6 February 2013 08:29 CET]
The original version is still available [246 KB, uploaded 5 February 2013 15:28 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Rudraraju, R.; Jones, B.G.; Sealy, R.; Surman, S.L.; Hurwitz, J.L. Respiratory Syncytial Virus: Current Progress in Vaccine Development. Viruses 2013, 5, 577-594.

AMA Style

Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL. Respiratory Syncytial Virus: Current Progress in Vaccine Development. Viruses. 2013; 5(2):577-594.

Chicago/Turabian Style

Rudraraju, Rajeev; Jones, Bart G.; Sealy, Robert; Surman, Sherri L.; Hurwitz, Julia L. 2013. "Respiratory Syncytial Virus: Current Progress in Vaccine Development." Viruses 5, no. 2: 577-594.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert